Table of Content



Chapter Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Product
1.1.2 Route of Administration
1.1.3 Type of Disease
1.1.4 Regional Scope
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity flow analysis (Model 1)
1.6.2 Volume price analysis (Model 2)
1.7 List of Secondary Sources
1.8 Objectives
1.8.1 Objective - 1
1.8.2 Objective - 2
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.2.1 Product
2.2.2 Route of Administration
2.2.3 Type of Disease
2.2.4 Region
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration & Growth Prospect Mapping
3.2.1 Market Driver Analysis
3.2.2 Market Restraint Analysis
3.3 Hormone Replacement Therapy Market: Business Environment Analysis Tools
3.3.1 Porter’s Five Forces Analysis
3.3.1.1 Bargaining power of suppliers
3.3.1.2 Bargaining power of buyers
3.3.1.3 Threat of new entrants
3.3.1.4 Competitive rivalry
3.3.1.5 Threat of substitutes
3.3.2 PESTEL Analysis
3.3.2.1 Political & legal
3.3.2.2 Economic
3.3.2.3 Technological
Chapter 4 Hormone Replacement Therapy Market: Product Analysis
4.1 Hormone Replacement Therapy Product Market Share Analysis, 2019 & 2027
4.2 Hormone Replacement Therapy Product Market: Segment Dashboard
4.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Product Segment
4.3.1 Estrogen Hormone Replacement Therapy
4.3.1.1 Estrogen Hormone replacement therapy market, 2016 - 2027 (USD Million)
4.3.2 HGH Replacement Therapy
4.3.2.1 HGH replacement therapy market, 2016 - 2027 (USD Million)
4.3.3 Thyroid Hormone Replacement Therapy
4.3.3.1 Thyroid hormone replacement therapy market, 2016 - 2027 (USD Million)
4.3.4 Testosterone Hormone Replacement Therapy
4.3.4.1 Testosterone hormone replacement therapy market, 2016 - 2027 (USD Million)
Chapter 5 Hormone Replacement Therapy Market: Route of Administration Analysis
5.1 Hormone Replacement Therapy Route of Administration Market Share Analysis, 2019 & 2027
5.2 Hormone Replacement Therapy Route of Administration Market: Segment Dashboard
5.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Route of Administration Segment
5.3.1 Oral
5.3.1.1 Oral market, 2016 - 2027 (USD Million)
5.3.2 Parenteral
5.3.2.1 Parenteral market, 2016 - 2027 (USD Million)
5.3.3 Transdermal
5.3.3.1 Transdermal market, 2016 - 2027 (USD Million)
5.3.4 Others
5.3.4.1 Others market, 2016 - 2027 (USD Million)
Chapter 6 Hormone Replacement Therapy Market: Type of Disease Analysis
6.1 Hormone Replacement Therapy Type of Disease Market Share Analysis, 2019 & 2027
6.2 Hormone Replacement Therapy Type of Disease Market: Segment Dashboard
6.3 Market Size & Forecasts and Trend Analyses, 2016 to 2027 for the Type of Disease Segment
6.3.1 Menopause
6.3.1.1 Menopause market, 2016 - 2027 (USD Million)
6.3.2 Hypothyroidism
6.3.2.1 Hypothyroidism market, 2016 - 2027 (USD Million)
6.3.3 Male Hypogonadism
6.3.3.1 Male hypogonadism market, 2016 - 2027 (USD Million)
6.3.4 Growth Hormone Deficiency
6.3.4.1 Growth hormone deficiency market, 2016 - 2027 (USD Million)
6.3.5 Others
6.3.5.1 Others market, 2016 - 2027 (USD Million)
Chapter 7 Hormone Replacement Therapy Market: Regional Analysis
7.1 Hormone Replacement Therapy Regional Market Share Analysis, 2019 & 2027
7.2 Hormone Replacement Therapy Regional Market: Segment Dashboard
7.3 Regional Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
7.4 Market Size, & Forecasts, and Trend Analysis, 2016 to 2027
7.4.1 North America
7.4.1.1 North America hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.1.1.1 U.S.
7.4.1.1.1.1 U.S. hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.1.1.2 Canada
7.4.1.1.2.1 Canada hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.2 Europe
7.4.2.1 Europe Hormone Replacement Therapy market, 2016 - 2027 (USD Million)
7.4.2.1.1 U.K.
7.4.2.1.1.1 U.K. hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.2.1.2 Germany
7.4.2.1.2.1 Germany hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.3 Asia Pacific
7.4.3.1 Asia Pacific hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.3.1.1 Japan
7.4.3.1.1.1 Japan hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.3.1.2 China
7.4.3.1.2.1 China hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.4 Latin America
7.4.4.1 Latin America hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.4.1.1 Brazil
7.4.4.1.1.1 Brazil hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.4.1.2 Mexico
7.4.4.1.2.1 Mexico hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.5 Middle East and Africa (MEA)
7.4.5.1 MEA hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.5.1.1 South Africa
7.4.5.1.1.1 South Africa hormone replacement therapy market, 2016 - 2027 (USD Million)
7.4.5.1.2 Saudi Arabia
7.4.5.1.2.1 Saudi Arabia hormone replacement therapy market, 2016 - 2027 (USD Million)
Chapter 8 Competitive Analysis
8.1 Strategic Framework/ Competition Categorization (Key innovators, Market leaders, emerging players
8.2 Vendor Landscape
8.3 Company market position analysis (Geographic Presence, Product Portfolio, Strategic Initiatives, Employee Strength)
8.4 Company Profiles
8.4.1 Abbott Laboratories
8.4.1.1 Company overview
8.4.1.2 Financial performance
8.4.1.3 Product benchmarking
8.4.1.4 Strategic initiatives
8.4.2 Novartis
8.4.2.1 Company overview
8.4.2.2 Financial performance
8.4.2.3 Product benchmarking
8.4.2.4 Strategic initiatives
8.4.3 Pfizer
8.4.3.1 Company overview
8.4.3.2 Financial performance
8.4.3.3 Product benchmarking
8.4.3.4 Strategic initiatives
8.4.4 Mylan Laboratories
8.4.4.1 Company overview
8.4.4.2 Financial performance
8.4.4.3 Product benchmarking
8.4.4.4 Strategic initiatives
8.4.5 Merck & Co.
8.4.5.1 Company overview
8.4.5.2 Financial performance
8.4.5.3 Product benchmarking
8.4.5.4 Strategic initiatives
8.4.6 Amgen
8.4.6.1 Company overview
8.4.6.2 Financial performance
8.4.6.3 Product benchmarking
8.4.6.4 Strategic initiatives
8.4.7 Novo Nordisk
8.4.7.1 Company overview
8.4.7.2 Financial performance
8.4.7.3 Product benchmarking
8.4.7.4 Strategic initiatives
8.4.8 Bayer
8.4.8.1 Company overview
8.4.8.2 Financial performance
8.4.8.3 Product benchmarking
8.4.8.4 Strategic initiatives
8.4.9 Eli Lilly
8.4.9.1 Company overview
8.4.9.2 Financial performance
8.4.9.3 Product benchmarking
8.4.9.4 Strategic initiatives
8.4.10 Genentech
8.4.10.1 Company overview
8.4.10.2 Financial performance
8.4.10.3 Product benchmarking
8.4.10.4 Strategic initiatives



List of Tables



TABLE 1 List of secondary sources
TABLE 2 North America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 3 North America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 4 North America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 5 North America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 6 U.S. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 7 U.S. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 8 U.S. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 9 Canada hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 10 Canada hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 11 Canada hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 12 Europe hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 13 Europe hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 14 Europe hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 15 Europe hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 16 U.K. hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 17 U.K. hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 18 U.K. hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 19 Germany hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 20 Germany hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 21 Germany hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 22 Asia Pacific hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 23 Asia Pacific hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 24 Asia Pacific hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 25 Asia Pacific hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 26 Japan hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 27 Japan hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 28 Japan hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 29 China hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 30 China hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 31 China hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 32 Latin America hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 33 Latin America hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 34 Latin America hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 35 Latin America hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 36 Brazil hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 37 Brazil hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 38 Brazil hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 39 Mexico hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 40 Mexico hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 41 Mexicohormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 42 MEA hormone replacement therapy market, by region, 2016 - 2027 (USD Million)
TABLE 43 MEA hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 44 MEA hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 45 MEA hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 46 South Africa hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 47 South Africa hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 48 South Africa hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)
TABLE 49 Saudi Arabia hormone replacement therapy market, by product, 2016 - 2027 (USD Million)
TABLE 50 Saudi Arabia hormone replacement therapy market, by route of administration, 2016 - 2027 (USD Million)
TABLE 51 Saudi Arabia hormone replacement therapy market, by type of disease, 2016 - 2027 (USD Million)